Esketamine for Adolescents with Depression

A groundbreaking study Presented at the 2023 Annual Meeting of the American Psychiatric Association San Francisco, CA, demonstrates that esketamine nasal spray can rapidly reduce depressive symptoms in adolescents at high risk of suicide. 


Unlike previous antidepressant trials, this study includes a vulnerable patient population that has been traditionally overlooked: adolescents at immediate and imminent risk of suicide. These findings contribute to our understanding of the potential benefits of esketamine and highlight the importance of inclusivity in clinical trials to address the needs of all patient groups. This study was conducted on male or female teenagers between the ages of 12 and 18 who had been diagnosed with Major Depressive Disorder. 


The results of this study revealed a meaningful improvement in depressive symptoms, which was both statistically and clinically significant, observed just 24 hours after the initial administration of pooled Esketamine doses at 56 mg and 84 mg. In comparison to a psychoactive comparator, the use of esketamine demonstrated a clear advantage in alleviating depressive symptoms. Treatment with a psychological intervention (individual cognitive behavioral therapy, interpersonal therapy, family

therapy, psychodynamic psychotherapy) was also required, at least through the initial 8-week Post-Treatment Follow-Up phase.


These findings provide substantial evidence supporting the efficacy of esketamine as a potential treatment option for individuals struggling with depression. By showcasing its rapid action and significant impact, this study contributes to our understanding of the therapeutic potential of esketamine and highlights its superiority over existing psychoactive comparators.


This study indicated that the adolescents experienced a rapid decrease in depressive symptoms, which aligns with similar findings observed in phase 3 studies involving adults with Major Depressive Disorder (MDD) who were dealing with acute suicidal thoughts or behavior. It is noteworthy that there were no new or unexpected safety concerns identified in the adolescent participants, and these observations were consistent with previous trials conducted with adults at risk of suicide. 


These conclusions provide further evidence supporting the effectiveness and safety of the treatment across different age groups, highlighting its potential as a valuable intervention in addressing depression and reducing the risk of suicide in both adolescents and adults with MDD.


Here at Blue Umbrella, we proudly offer Spravato (EsKetamine) as a form of treatment for suicidal ideation. We have seen tremendous improvement in multiple dire cases and are excited to share this innovative and effective treatment option with the community.

References:


Colette Kosik-Gonzalez

MA1


Dong Jing Fu

MD, PhD1*


Li "Nancy" Chen

PhD1


Rosanne Lane

MAS1


Wayne C. Drevets

MD2


Carla M. Canuso

MD1


Janssen Research and Development, LLC

Titusville, NJ | San Diego, CA


Esketamine Nasal Spray versus Psychoactive Comparator for Rapid Reduction of Depressive Symptoms in adolescents at Imminent Suicide Risk, 2023

Sleep Problems and Mental Health: What’s the Connection?

February 18, 2026
Most of us have had a rough night of sleep and felt the effects the next day—irritable, foggy, unfocused, or emotionally sensitive. But when sleep problems become ongoing, they can affect much more than just energy levels. There’s a strong, two-way relationship between sleep and mental health, and understanding that connection is an important step toward feeling better. At Blue Umbrella Psychiatry, we often see how closely sleep and emotional well-being are intertwined. Let’s take a closer look at why sleep matters so much for mental health—and what to do when it’s not going well.

What to Expect When Starting an Antidepressant

February 11, 2026
What to Expect When Starting an Antidepressant 

Why Talking to Others Is Good for Your Mental Health (Even When It Feels Hard)

February 5, 2026
Why Talking to Others Is Good for Your Mental Health (Even When It Feels Hard)

Building Confidence Through Small Wins

January 29, 2026
How Small Wins Build Confidence and Resilience

Mindfulness and Coping Skills for the New Year

January 22, 2026
As the new year begins, many people resolve to improve physical health, but emotional and mental well-being is just as crucial. Stress, anxiety, and overwhelming responsibilities can accumulate, making it difficult to focus, sleep, or feel at ease. Mindfulness and coping strategies are evidence-based tools that can improve emotional regulation, resilience, and overall quality of life.

Understanding Anxiety and Avoidance in Teens

January 15, 2026
Anxiety is one of the most common mental health challenges in adolescence. According to the Anxiety & Depression Association of America, nearly 1 in 3 adolescents experiences an anxiety disorder at some point, often leading to avoidance behaviors. Avoidance may provide temporary relief but can reinforce fears and limit personal growth.

Vibe & Thrive Teen Social Skills Group

January 8, 2026
Adolescence is a critical time for social development. Teens are learning to navigate friendships, school environments, and extracurricular activities, all while managing the emotional changes of growing up. Many teens experience anxiety, social discomfort, or avoidance behaviors that can impact their ability to engage with peers confidently.  Blue Umbrella Psychiatry is excited to introduce the Vibe & Thrive Teen Social Skills Group, designed for teens aged 13–17 to practice social skills, reduce anxious thoughts, and build confidence in a safe and supportive environment.

Setting Meaningful Mental Health Goals in 2026

January 1, 2026
As we step into a new year, it’s natural to reflect on what we’ve achieved and what we hope to accomplish in the months ahead. While physical health goals often take center stage, mental health is equally important. Prioritizing emotional wellness, resilience, and personal growth can set the tone for a fulfilling 2026.

Reflecting on Your Mental Health Journey in 2025

December 25, 2025
On this Christmas Day, we want to take a moment to thank our patients for letting Blue Umbrella Psychiatry be a part of your mental health journey in 2025. Your trust in us means the world, and we’re especially grateful to those who referred family and friends, joined our therapy groups, and moved with us to our new location. You make our community stronger, and we truly appreciate every one of you.  The end of the year is a great time to pause, reflect, and celebrate the progress you’ve made—even small steps matter. Whether it was attending sessions regularly, trying new coping strategies, or supporting a loved one’s mental health, your commitment deserves recognition.

Healthy Holiday Habits for Mind and Body

December 18, 2025
The holiday season can be joyful, but it can also bring stress, irregular routines, and emotional challenges. At Blue Umbrella Psychiatry, we understand how the holidays affect mental health, and we’re here to offer practical strategies to help you maintain balance, manage stress, and enjoy the season.